Vienna 2026

From 12-Month Initiative to Lifelong Community: EURETINA Unveils Global Mentorship Alumni Network

Session on inherited retinal diseases and paediatrics  featured talks addressing unmet needs, updates on outcomes of patients treated with voretigene neparvovec gene therapy, and new insights about select genetic diseases. 

From 12-Month Initiative to Lifelong Community: EURETINA Unveils Global Mentorship Alumni Network Read More »

Navigating the Frontier of IRDs: Expert Perspectives on Luxturna Outcomes, Genotype Stratification, and AI-Driven Trial Endpoints

Session on inherited retinal diseases and paediatrics  featured talks addressing unmet needs, updates on outcomes of patients treated with voretigene neparvovec gene therapy, and new insights about select genetic diseases. 

Navigating the Frontier of IRDs: Expert Perspectives on Luxturna Outcomes, Genotype Stratification, and AI-Driven Trial Endpoints Read More »

Frontiers in Retinal Innovation: Late-Breaking Trial Results Highlight Gene Therapies, Subretinal Implants, and Extended Delivery in nAMD and GA

Nine speakers present results from preclinical and in-human clinical trials of interventions designed for patients with genetic diseases, neovascular age-related macular degeneration (nAMD), and geographic atrophy (GA). 

Frontiers in Retinal Innovation: Late-Breaking Trial Results Highlight Gene Therapies, Subretinal Implants, and Extended Delivery in nAMD and GA Read More »